NanoEcho AB (publ) OMXSTO:NANECH:
ANNOUNCES RESULTS FROM INITIAL PART OF EXPLORATORY PROOF OF CONCEPT (POC) STUDY IN HEALTHY STUDY PARTICIPANTS
STUDY DID NOT ACHIEVE PRIMARY ENDPOINT
PRIMARY ENDPOINT WAS TO VALIDATE PREVIOUSLY ESTABLISHED DOSE OF NANOPARTICLE NEP-01, TIMING OF EXAMINATION WITH CO'S DIAGNOSTIC SYSTEM
NO SERIOUS ADVERSE EFFECTS HAVE BEEN REPORTED DURING STUDY
BASED ON RESULTS, CO TO EVALUATE WHETHER ANY ADJUSTMENTS TO DIAGNOSTIC SYSTEM, METHOD MAY BE RELEVANT FOR NEXT PART OF POC STUDY